Enrique Miranda
-
- Monoclonal and Polyclonal Antibodies Research 7
- Oncology top 10%
- HER2/EGFR in Cancer Research 6
- CAR-T cell therapy research 3
- Biotechnology top 10%
- Organic Chemistry top 10%
-
- RNA Interference and Gene Delivery 3
- Protein purification and stability 2
-
- Virus-based gene therapy research 3
-
- Nanofabrication and Lithography Techniques 2
-
- Viral gastroenteritis research and epidemiology 1
- Co-authors
- Kerry ChesterMark E. B. SmithVijay ChudasamaAntoine MaruaniStephen CaddickJames R. BakerNicholas R. LemoineGunnel Halldén
- Partner nations
- United KingdomMexicoPortugal
In The Last Decade
Enrique Miranda
15 papers receiving 652 citations
Peers
Comparison fields: 5 of 64
- Radiology, Nuclear Medicine and Imaging 316
- Oncology 320
- Biotechnology 60
- Organic Chemistry 162
- Molecular Biology 370
Countries citing papers authored by Enrique Miranda
This map shows the geographic impact of Enrique Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Miranda more than expected).
Fields of papers citing papers by Enrique Miranda
This network shows the impact of papers produced by Enrique Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Miranda. The network helps show where Enrique Miranda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Enrique Miranda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 15 | |
| 2 | 2018 | 45 | |
| 3 | 2015 | 197 | |
| 4 | 2015 | 13 | |
| 5 | 2014 | 74 | |
| 6 | 2014 | 50 | |
| 7 | 2013 | 61 | |
| 8 | 2013 | 12 | |
| 9 | 2012 | 12 | |
| 10 | 2011 | 8 | |
| 11 | 2010 | 25 | |
| 12 | 2009 | 60 | |
| 13 | 2005 | 11 | |
| 14 | [Acute cholestatic hepatitis caused by propafenone. Report of a case and review of the literature]. | 2001 | 4 |
| 15 | 1997 | 77 |
About Enrique Miranda
Enrique Miranda is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 15 papers that have together received 664 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers), Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers), RNA Interference and Gene Delivery (3 papers), Nanofabrication and Lithography Techniques (2 papers), Protein purification and stability (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (316 citations), Oncology (320 citations) and Biotechnology (60 citations). Enrique Miranda has collaborated with scholars based in United Kingdom, Mexico and Portugal. Frequent co-authors include Kerry Chester, Mark E. B. Smith, Vijay Chudasama, Antoine Maruani, Stephen Caddick, James R. Baker, Nicholas R. Lemoine, Gunnel Halldén, Alejandro Garcı́a-Carrancá and Emilio Rojas. Their work appears in journals such as Nature Communications, PLoS ONE and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.